(ML) Compagnie Generale des - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR001400AJ45
Stock: Tires, Mobility, Materials, Accessories
Total Rating 41
Risk 85
Buy Signal -0.60
| Risk 5d forecast | |
|---|---|
| Volatility | 27.1% |
| Relative Tail Risk | -11.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -16.36 |
| Character TTM | |
|---|---|
| Beta | 0.498 |
| Beta Downside | 0.443 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.18% |
| CAGR/Max DD | 0.26 |
EPS (Earnings per Share)
Revenue
Description: ML Compagnie Generale des March 04, 2026
Michelin manufactures and sells tires globally. The companys product range covers diverse applications, from consumer vehicles like cars and motorcycles to commercial uses in freight, agriculture, and mining. This dual market approach (consumer and commercial) is common in the tire industry, balancing stable replacement demand with cyclical OEM sales.
Beyond tires, Michelin provides tire-related services, including mobility solutions for fleet management. It also offers mobility services like navigation tools and travel guides. Additionally, the company produces lifestyle products and high-tech materials, including advanced rubber and recycled composites. Diversification into services and materials is a strategy many mature industrial companies employ to capture additional value streams and mitigate core product cyclicality. Investors can find further detailed analysis on ValueRay.
Headlines to watch out for
- Global automotive production directly impacts tire demand
- Raw material price volatility affects production costs
- Competition from low-cost tire manufacturers pressures margins
- Economic downturns reduce consumer and commercial tire purchases
- Regulatory shifts in vehicle emissions influence tire technology
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 3.55b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 0.79 > 1.0 |
| NWC/Revenue: 12.73% < 20% (prev 11.69%; Δ 1.04% < -1%) |
| CFO/TA 0.23 > 3% & CFO 8.15b > Net Income 3.55b |
| Net Debt (2.93b) to EBITDA (8.99b): 0.33 < 3 |
| Current Ratio: 1.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (697.7m) vs 12m ago -3.04% < -2% |
| Gross Margin: 28.74% > 18% (prev 0.27%; Δ 2847 % > 0.5%) |
| Asset Turnover: 151.5% > 50% (prev 144.0%; Δ 7.49% > 0%) |
| Interest Coverage Ratio: 9.00 > 6 (EBITDA TTM 8.99b / Interest Expense TTM 577.0m) |
Altman Z'' 4.92
| A: 0.19 (Total Current Assets 14.27b - Total Current Liabilities 7.50b) / Total Assets 35.02b |
| B: 0.49 (Retained Earnings 17.01b / Total Assets 35.02b) |
| C: 0.15 (EBIT TTM 5.19b / Avg Total Assets 35.11b) |
| D: 1.02 (Book Value of Equity 17.36b / Total Liabilities 16.94b) |
| Altman-Z'' Score: 4.92 = AAA |
Beneish M -3.49
| DSRI: 0.68 (Receivables 3.47b/4.88b, Revenue 53.19b/50.68b) |
| GMI: 0.94 (GM 28.74% / 26.94%) |
| AQI: 0.92 (AQ_t 0.22 / AQ_t-1 0.23) |
| SGI: 1.05 (Revenue 53.19b / 50.68b) |
| TATA: -0.13 (NI 3.55b - CFO 8.15b) / TA 35.02b) |
| Beneish M-Score: -3.49 (Cap -4..+1) = AA |
What is the price of ML shares?
As of March 11, 2026, the stock is trading at EUR 30.90 with a total of 1,792,762 shares traded.
Over the past week, the price has changed by -2.34%, over one month by -5.45%, over three months by +12.20% and over the past year by -9.03%.
Over the past week, the price has changed by -2.34%, over one month by -5.45%, over three months by +12.20% and over the past year by -9.03%.
Is ML a buy, sell or hold?
Compagnie Generale des has no consensus analysts rating.
What are the forecasts/targets for the ML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.8 | 6.1% |
| Analysts Target Price | - | - |
ML Fundamental Data Overview March 07, 2026
Market Cap USD = 25.74b (22.35b EUR * 1.1513 EUR.USD)
P/E Trailing = 3.0605
P/E Forward = 9.0171
P/S = 0.8757
P/B = 1.2145
P/EG = 6.991
Revenue TTM = 53.19b EUR
EBIT TTM = 5.19b EUR
EBITDA TTM = 8.99b EUR
Long Term Debt = 5.03b EUR (from longTermDebt, last quarter)
Short Term Debt = 854.0m EUR (from shortTermDebt, last quarter)
Debt = 6.61b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.93b EUR (from netDebt column, last quarter)
Enterprise Value = 24.99b EUR (22.35b + Debt 6.61b - CCE 3.97b)
Interest Coverage Ratio = 9.00 (Ebit TTM 5.19b / Interest Expense TTM 577.0m)
EV/FCF = 6.04x (Enterprise Value 24.99b / FCF TTM 4.14b)
FCF Yield = 16.56% (FCF TTM 4.14b / Enterprise Value 24.99b)
FCF Margin = 7.78% (FCF TTM 4.14b / Revenue TTM 53.19b)
Net Margin = 6.68% (Net Income TTM 3.55b / Revenue TTM 53.19b)
Gross Margin = 28.74% ((Revenue TTM 53.19b - Cost of Revenue TTM 37.90b) / Revenue TTM)
Gross Margin QoQ = 26.61% (prev 28.17%)
Tobins Q-Ratio = 0.71 (Enterprise Value 24.99b / Total Assets 35.02b)
Interest Expense / Debt = 3.37% (Interest Expense 223.0m / Debt 6.61b)
Taxrate = 26.08% (439.0m / 1.68b)
NOPAT = 3.84b (EBIT 5.19b * (1 - 26.08%))
Current Ratio = 1.90 (Total Current Assets 14.27b / Total Current Liabilities 7.50b)
Debt / Equity = 0.37 (Debt 6.61b / totalStockholderEquity, last quarter 18.07b)
Debt / EBITDA = 0.33 (Net Debt 2.93b / EBITDA 8.99b)
Debt / FCF = 0.71 (Net Debt 2.93b / FCF TTM 4.14b)
Total Stockholder Equity = 18.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.12% (Net Income 3.55b / Total Assets 35.02b)
RoE = 19.67% (Net Income TTM 3.55b / Total Stockholder Equity 18.07b)
RoCE = 22.48% (EBIT 5.19b / Capital Employed (Equity 18.07b + L.T.Debt 5.03b))
RoIC = 15.76% (NOPAT 3.84b / Invested Capital 24.34b)
WACC = 6.55% (E(22.35b)/V(28.96b) * Re(7.75%) + D(6.61b)/V(28.96b) * Rd(3.37%) * (1-Tc(0.26)))
Discount Rate = 7.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.53%
[DCF] Terminal Value 86.13% ; FCFF base≈4.04b ; Y1≈4.98b ; Y5≈8.48b
[DCF] Fair Price = 279.1 (EV 202.01b - Net Debt 2.93b = Equity 199.09b / Shares 713.3m; r=6.55% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -21.01 | EPS CAGR: -64.01% | SUE: -0.75 | # QB: 0
Revenue Correlation: 43.18 | Revenue CAGR: 44.04% | SUE: -0.17 | # QB: 0
EPS current Year (2026-12-31): EPS=2.83 | Chg7d=-0.035 | Chg30d=-0.020 | Revisions Net=+2 | Growth EPS=+21.3% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=3.26 | Chg7d=-0.030 | Chg30d=-0.027 | Revisions Net=+0 | Growth EPS=+15.5% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -24.7% (Discount Rate 7.9% - Earnings Yield 32.7%)
[Growth] Growth Spread = +28.4% (Analyst 3.7% - Implied -24.7%)
P/E Trailing = 3.0605
P/E Forward = 9.0171
P/S = 0.8757
P/B = 1.2145
P/EG = 6.991
Revenue TTM = 53.19b EUR
EBIT TTM = 5.19b EUR
EBITDA TTM = 8.99b EUR
Long Term Debt = 5.03b EUR (from longTermDebt, last quarter)
Short Term Debt = 854.0m EUR (from shortTermDebt, last quarter)
Debt = 6.61b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.93b EUR (from netDebt column, last quarter)
Enterprise Value = 24.99b EUR (22.35b + Debt 6.61b - CCE 3.97b)
Interest Coverage Ratio = 9.00 (Ebit TTM 5.19b / Interest Expense TTM 577.0m)
EV/FCF = 6.04x (Enterprise Value 24.99b / FCF TTM 4.14b)
FCF Yield = 16.56% (FCF TTM 4.14b / Enterprise Value 24.99b)
FCF Margin = 7.78% (FCF TTM 4.14b / Revenue TTM 53.19b)
Net Margin = 6.68% (Net Income TTM 3.55b / Revenue TTM 53.19b)
Gross Margin = 28.74% ((Revenue TTM 53.19b - Cost of Revenue TTM 37.90b) / Revenue TTM)
Gross Margin QoQ = 26.61% (prev 28.17%)
Tobins Q-Ratio = 0.71 (Enterprise Value 24.99b / Total Assets 35.02b)
Interest Expense / Debt = 3.37% (Interest Expense 223.0m / Debt 6.61b)
Taxrate = 26.08% (439.0m / 1.68b)
NOPAT = 3.84b (EBIT 5.19b * (1 - 26.08%))
Current Ratio = 1.90 (Total Current Assets 14.27b / Total Current Liabilities 7.50b)
Debt / Equity = 0.37 (Debt 6.61b / totalStockholderEquity, last quarter 18.07b)
Debt / EBITDA = 0.33 (Net Debt 2.93b / EBITDA 8.99b)
Debt / FCF = 0.71 (Net Debt 2.93b / FCF TTM 4.14b)
Total Stockholder Equity = 18.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.12% (Net Income 3.55b / Total Assets 35.02b)
RoE = 19.67% (Net Income TTM 3.55b / Total Stockholder Equity 18.07b)
RoCE = 22.48% (EBIT 5.19b / Capital Employed (Equity 18.07b + L.T.Debt 5.03b))
RoIC = 15.76% (NOPAT 3.84b / Invested Capital 24.34b)
WACC = 6.55% (E(22.35b)/V(28.96b) * Re(7.75%) + D(6.61b)/V(28.96b) * Rd(3.37%) * (1-Tc(0.26)))
Discount Rate = 7.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.53%
[DCF] Terminal Value 86.13% ; FCFF base≈4.04b ; Y1≈4.98b ; Y5≈8.48b
[DCF] Fair Price = 279.1 (EV 202.01b - Net Debt 2.93b = Equity 199.09b / Shares 713.3m; r=6.55% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -21.01 | EPS CAGR: -64.01% | SUE: -0.75 | # QB: 0
Revenue Correlation: 43.18 | Revenue CAGR: 44.04% | SUE: -0.17 | # QB: 0
EPS current Year (2026-12-31): EPS=2.83 | Chg7d=-0.035 | Chg30d=-0.020 | Revisions Net=+2 | Growth EPS=+21.3% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=3.26 | Chg7d=-0.030 | Chg30d=-0.027 | Revisions Net=+0 | Growth EPS=+15.5% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -24.7% (Discount Rate 7.9% - Earnings Yield 32.7%)
[Growth] Growth Spread = +28.4% (Analyst 3.7% - Implied -24.7%)